Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study

William J. Gradishar*, Luis A. Meza, Bipinkumar Amin, Dvorit Samid, Todd Hill, Yin Miao Chen, Elyse E. Lower, P. Kelly Marcom

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Fingerprint Dive into the research topics of 'Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: A multicenter phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences